Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $10.80 billion. The enterprise value is $10.40 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 140.86 million shares outstanding. The number of shares has increased by 9.83% in one year.
| Current Share Class | 140.86M |
| Shares Outstanding | 140.86M |
| Shares Change (YoY) | +9.83% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 3.30% |
| Owned by Institutions (%) | 80.64% |
| Float | 122.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.36 |
| Forward PS | 59.40 |
| PB Ratio | 17.55 |
| P/TBV Ratio | 17.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.23, with a Debt / Equity ratio of 2.31.
| Current Ratio | 6.23 |
| Quick Ratio | 6.09 |
| Debt / Equity | 2.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.40 |
Financial Efficiency
Return on equity (ROE) is -42.37% and return on invested capital (ROIC) is -81.18%.
| Return on Equity (ROE) | -42.37% |
| Return on Assets (ROA) | -7.22% |
| Return on Invested Capital (ROIC) | -81.18% |
| Return on Capital Employed (ROCE) | -11.25% |
| Weighted Average Cost of Capital (WACC) | 10.65% |
| Revenue Per Employee | $874,837 |
| Profits Per Employee | -$423,221 |
| Employee Count | 711 |
| Asset Turnover | 0.32 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ARWR has paid $19.60 million in taxes.
| Income Tax | 19.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +414.22% in the last 52 weeks. The beta is 1.29, so ARWR's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | +414.22% |
| 50-Day Moving Average | 66.47 |
| 200-Day Moving Average | 51.64 |
| Relative Strength Index (RSI) | 56.62 |
| Average Volume (20 Days) | 1,779,231 |
Short Selling Information
The latest short interest is 12.94 million, so 9.19% of the outstanding shares have been sold short.
| Short Interest | 12.94M |
| Short Previous Month | 12.01M |
| Short % of Shares Out | 9.19% |
| Short % of Float | 10.53% |
| Short Ratio (days to cover) | 7.31 |
Income Statement
In the last 12 months, ARWR had revenue of $622.01 million and -$300.91 million in losses. Loss per share was -$2.17.
| Revenue | 622.01M |
| Gross Profit | 622.01M |
| Operating Income | -221.90M |
| Pretax Income | -252.26M |
| Net Income | -300.91M |
| EBITDA | -196.53M |
| EBIT | -221.90M |
| Loss Per Share | -$2.17 |
Full Income StatementBalance Sheet
The company has $1.78 billion in cash and $1.38 billion in debt, with a net cash position of $398.40 million or $2.83 per share.
| Cash & Cash Equivalents | 1.78B |
| Total Debt | 1.38B |
| Net Cash | 398.40M |
| Net Cash Per Share | $2.83 |
| Equity (Book Value) | 598.92M |
| Book Value Per Share | 4.37 |
| Working Capital | 1.54B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$36.31 million and capital expenditures -$14.57 million, giving a free cash flow of -$50.87 million.
| Operating Cash Flow | -36.31M |
| Capital Expenditures | -14.57M |
| Depreciation & Amortization | 25.37M |
| Net Borrowing | 575.75M |
| Free Cash Flow | -50.87M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -35.67% and -48.38%.
| Gross Margin | 100.00% |
| Operating Margin | -35.67% |
| Pretax Margin | -40.56% |
| Profit Margin | -48.38% |
| EBITDA Margin | -31.60% |
| EBIT Margin | -35.67% |
| FCF Margin | n/a |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.83% |
| Shareholder Yield | -9.83% |
| Earnings Yield | -2.79% |
| FCF Yield | -0.47% |
Analyst Forecast
The average price target for ARWR is $87.09, which is 13.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $87.09 |
| Price Target Difference | 13.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 21.87% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ARWR has an Altman Z-Score of 1.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.53 |
| Piotroski F-Score | 2 |
